CID 46213929

Gandotinib

Structural Information

Molecular Formula
C23H25ClFN7O
SMILES
CC1=CC(=NN1)NC2=NN3C(=C(N=C3C(=C2)CN4CCOCC4)C)CC5=C(C=C(C=C5)Cl)F
InChI
InChI=1S/C23H25ClFN7O/c1-14-9-21(29-28-14)27-22-11-17(13-31-5-7-33-8-6-31)23-26-15(2)20(32(23)30-22)10-16-3-4-18(24)12-19(16)25/h3-4,9,11-12H,5-8,10,13H2,1-2H3,(H2,27,28,29,30)
InChIKey
SQSZANZGUXWJEA-UHFFFAOYSA-N
Compound name
3-[(4-chloro-2-fluorophenyl)methyl]-2-methyl-N-(5-methyl-1H-pyrazol-3-yl)-8-(morpholin-4-ylmethyl)imidazo[1,2-b]pyridazin-6-amine
Related CIDs

2D Structure

compound 2d structure
2
Annotation Hits

28
References

775
Patents

469.17932 Da
Monoisotopic Mass

3.8
XlogP (predicted)

Profile

Predicted Collision Cross Section

Adduct m/z Predicted CCS (Ų)
[M+H]+ 470.18660 212.7
[M+Na]+ 492.16854 227.6
[M+NH4]+ 487.21314 217.5
[M+K]+ 508.14248 223.6
[M-H]- 468.17204 217.7
[M+Na-2H]- 490.15399 218.5
[M]+ 469.17877 216.4
[M]- 469.17987 216.4
m/z: mass to charge ratio of the adduct.
Predicted Collision Cross Section (CCS) values (Ų) per adduct calculated using CCSbase.

Literature stripe

literature stripe

Patent stripe

patents stripe